Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
about
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesThe clinical and functional significance of c-Met in breast cancer: a reviewBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.Clinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.Mesenchymal/stromal gene expression signature relates to basal-like breast cancers, identifies bone metastasis and predicts resistance to therapies.p16INK4a expression in basal-like breast carcinoma.TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.Relation between radiographic BI-RADS scores and triple negativity in patients with ductal carcinomas.Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patientsPrevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.Characteristics of triple-negative breast cancerMolecular Heterogeneity of Triple Negative Breast Cancer.The number of tumor-free axillary lymph nodes removed as a prognostic parameter for node-negative breast cancerSubtyping of triple-negative breast cancer: implications for therapyAssociations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.Mouse mammary stem cells express prognostic markers for triple-negative breast cancerClinical significance of morphologic characteristics in triple negative breast cancer.Triple-Negative Breast Cancer: Clinical and Histological Correlations.Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.Expression of HIF-1α and Markers of Angiogenesis Are Not Significantly Different in Triple Negative Breast Cancer Compared to Other Breast Cancer Molecular Subtypes: Implications for Future TherapyTriple-negative breast cancer: adjuvant therapeutic options.Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survivalIdentification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity.Genetic characterization of breast cancer and implications for clinical managementBasal breast cancer: a complex and deadly molecular subtypeCommon genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes.Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomasThe histological diagnosis of metastases to the breast from extramammary malignanciesDemystifying basal-like breast carcinomasUpdate on triple-negative breast cancer: prognosis and management strategiesA comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas.P-cadherin expression in breast cancer: a review.BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies.Which imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer?
P2860
Q26743510-FD3A71D0-6D40-4DB9-8068-897EEF8672C3Q28081415-2C66D0EC-6B2D-4F75-ABCB-AE579337EF51Q30245184-718C5802-A542-48FB-A0F0-4507F1952D7EQ30496322-2AD0CC17-3309-4FC1-A52A-6EEF75AB1FE8Q33416006-9D68C8DF-A39B-4105-8E15-1558AED594DFQ33646271-B3DDBE90-87FD-42F2-82B5-5D6DC894E43AQ33751806-6B872C45-497C-49D9-B8D1-59D42F614AB1Q33770298-D92C2B98-013E-42F3-A73E-E24B1A286327Q34007463-4F194306-1A15-4DDF-BE63-C0D9D66C9315Q34130168-FF854AA7-DB61-465E-B95B-DA3800127198Q34167298-095581FE-7C5B-4B9D-B5F7-8FB73CD08050Q34248718-3859248A-49A1-4B48-848F-C26168832071Q34275213-052207BC-0A87-458A-8D8B-6C7CC1BD6121Q34378272-60896626-F9BE-4E8B-998E-3DA672A4C5A7Q34392810-080EDF35-B1A5-40D3-BD4A-09DA056A12ABQ34479003-1512E961-11C2-4BBB-92F8-7F0838F524DBQ34533964-37DF68C0-BFC7-43D9-8C2F-B04809353CEFQ34572806-91010EBB-7ABF-45E8-A16B-158265DC9A17Q34734477-B0BAC104-BED1-4301-AE94-23941E42C1D6Q35022847-60281409-C904-4D69-BB1A-3DA2E09DF039Q35168065-C4845577-99C4-44A5-81DC-D2B9297695BCQ35238287-FF1545F3-4E0E-49E4-829C-06344AF488F4Q35483406-E31A6FB3-CD47-4680-BADB-04B4DB4082E2Q35576252-EC1894AE-DBE6-460F-8E4F-42A3CD9314DDQ35602598-6764DE8A-EB9F-40C8-869D-EEC04EFDD742Q35654022-CEFCD32C-D61F-449A-8E31-03F22ABE1AEBQ35692146-1431CE1C-AC4D-48E6-93C2-DCDCDF87471AQ35749421-14CFE4BB-B3E1-41A0-A82C-BA593D76CF23Q35794363-22AC696B-430B-4CC2-815C-10F236EC1869Q35832016-21F602F8-4BC0-4BED-945C-935CE89DC59CQ35931900-3876C679-45A6-457C-A89E-4F8359FFA785Q35970493-03BE1BD0-8577-4243-9864-E2C051C27975Q35984566-805C9ACF-7AE7-42DB-9155-02506C92E287Q36172504-D541B701-8AF8-4E7F-A61B-CEFDF0B2F65BQ36172507-712E4E64-21BB-4439-A980-A0E994FFC54BQ36311616-AB915037-EFF3-4812-A70D-E531CCE18D4DQ36369621-8E512C77-CA3D-4C55-A6F1-0D4EAB24584EQ36458759-6F909D26-9082-4A25-99E9-2B81F424BB69Q36556331-F928AA9B-79D7-4AB3-A5D2-ACDCFD4060AAQ36640972-F8773328-072C-4513-900D-42E4CE173B96
P2860
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Specific morphological feature ...... ve ductal carcinoma of breast.
@ast
Specific morphological feature ...... ve ductal carcinoma of breast.
@en
type
label
Specific morphological feature ...... ve ductal carcinoma of breast.
@ast
Specific morphological feature ...... ve ductal carcinoma of breast.
@en
prefLabel
Specific morphological feature ...... ve ductal carcinoma of breast.
@ast
Specific morphological feature ...... ve ductal carcinoma of breast.
@en
P2093
P2860
P1433
P1476
Specific morphological feature ...... ve ductal carcinoma of breast.
@en
P2093
Fulford LG
Gillett CE
Reis-Filho JS
Sofronis A
P2860
P356
10.1111/J.1365-2559.2006.02453.X
P577
2006-07-01T00:00:00Z